Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
09/2010
09/02/2010WO2010098286A1 Pharmaceutical preparation containing mineralcorticoid receptor antagonist
09/02/2010WO2010098119A1 Complex compound and organic electroluminescent device containing the complex compound
09/02/2010WO2010098098A1 Pyrromethene-boron complex compounds and organic electro- luminescent elements using same
09/02/2010WO2010097802A2 A process for the preparation of etoricoxib
09/02/2010WO2010097686A1 An improved process for the preparation of carbapenem antibiotic
09/02/2010WO2010097372A1 Compounds as bradykinin b1 antagonists
09/02/2010US20100222599 Processes for the preparation of sglt2 inhibitors
09/02/2010US20100222581 Novel isophthalates as beta-secretase inhibitors
09/02/2010US20100222576 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
09/02/2010US20100222405 Magnesium salts of hmg-coa reductase inhibitors
09/02/2010US20100222396 4-aryl-butane-1,3-diamides
09/02/2010US20100222386 Substituted piperidines
09/02/2010US20100222326 New Heterocyclic Derivatives Useful For The Treatment of CNS Disorders
09/02/2010US20100221749 Three-functional pseudo-peptidic reagent, and uses and applications thereof
09/02/2010US20100219063 Oxidative degeneration products of atorvastatin calcium
09/02/2010CA2759126A1 New compounds
09/01/2010EP2224013A1 Methods for the determination of telomerase activity using click chemistry
09/01/2010EP2222639A1 Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders
09/01/2010EP2222638A2 Biaryl pde4 inhibitors for treating inflammation
09/01/2010EP2222637A1 Amidine-containing compounds useful as muscarinic receptor antagonists
09/01/2010EP2222636A2 Selective androgen receptor modulators (sarms) and uses thereof
09/01/2010EP1856096B1 Phenylglycinamide derivatives useful as anticoagulants
09/01/2010EP1701945B1 Labeling reagents, labeled analytes, including mixtures thereof, and fragment ions derived therefrom and methods for the analysis thereof
09/01/2010EP1430027B1 Novel aminoazetidine, -pyrrolidine and -piperidine derivatives
09/01/2010EP1285651B1 Melanin concentrating hormone antagonists
09/01/2010EP1028942B1 Dipeptide nitriles
09/01/2010CN101821671A Liquid crystal aligning agent, method for producing liquid crystal alignment film, and liquid crystal display device
09/01/2010CN101821236A Five-membered heterocyclic compound
09/01/2010CN101821235A Pyrrolidin-2 -one derivatives as androgen receptor modulator
09/01/2010CN101821234A Phenoxy-pyrrolidine derivative and its use and compositions
09/01/2010CN101820759A Fungicidal n-cycloalkyl-benzyl-thiocarboxamides or n-cycloalkyl-benzyl-n' -substituted-amidine derivatives
09/01/2010CN101819381A Photosensitive monomer, liquid crystal panel and manufacturing method thereof
09/01/2010CN101817784A Ethylene derivatives and pesticides containing said derivatives
09/01/2010CN101817777A Photosensitive monomer, liquid crystal panel and manufacturing method thereof
09/01/2010CN101817776A Method for synthesizing 9-fluorenylmethoxycarbonyloxy succinimide ester
09/01/2010CN101817775A Preparation method of 2-pyrrole benzenylsulfonylamide compound
09/01/2010CN101817774A Method for preparing 2-(2-nitrophenyl) pyrrole and 2,5-bis(2-nitrophenyl) pyrrole compounds
09/01/2010CN101817773A Preparation method of chiral alpha-non-natural amino acid
08/2010
08/31/2010US7786305 Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity
08/31/2010US7786165 Antidiabetic agents; obesity; insulin resistance; neurodegenerative diseases; Alzheimer's disease
08/31/2010US7786150 substituted pyrrolidine derivatives, used for the treatment vision defects such as glaucoma or ocular hypertension
08/31/2010US7786145 Cyanoguanidine-based azole compounds useful as malonyl-CoA decarboxylase inhibitors
08/31/2010US7786122 use to treat Alzheimer's Disease; (2R)-2-[N-(4-Chlorobenzenesulfonyl)-N-(4-methoxybenzyl)amino]-4-methylpentanoic acid amide for example
08/31/2010US7786119 Drug conjugates of ion channel modulating compounds
08/31/2010CA2569861C Pyrrolidine derivatives as ccr5 antagonists
08/31/2010CA2549558C Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
08/31/2010CA2450773C Method of the solid phase synthesis of pyrrole-imidazole polyamide
08/31/2010CA2269399C Ocular devices manufactured with free radical-polymerizable latent ultra-violet absorbers
08/26/2010WO2010096722A1 3-oxo-2, 3-dihydro- [1,2, 4] triazolo [4, 3-a]pyridines as soluble epoxide hydrolase (seh) inhibitors
08/26/2010WO2010096677A2 Dihydrolipoic acid derivatives comprising nitric oxide and therapeutic uses thereof
08/26/2010WO2010095082A1 High safety lithium-ion battery
08/26/2010WO2010094678A1 Novel ortho-aminoamides for the treatment of cancer
08/26/2010WO2010094667A1 Pyrrolidine derivatives as nk3 receptor antagonists
08/26/2010WO2010094666A2 Fungicidal n-(phenylcycloalkyl)carboxamide, n-(benzylcycloalkyl)carboxamide and thiocarboxamide derivatives
08/26/2010WO2010076033A9 Toluidine sulfonamides and their use
08/26/2010WO2010053323A3 Cytoplasm exposure additive for exposing particles delivered into cells to cytoplasm from endocytic vesicles, and exposing method
08/26/2010US20100217014 Synthetic processes for the preparation of aminocyclohexyl ether compounds
08/26/2010US20100217011 [f-18]-labeled l-glutamic acid, [f-18]-labeled l-glutamine, derivatives thereof and use thereof and processes for their preparation
08/26/2010US20100216862 Pyrrole Derivatives As Therapeutic Compounds
08/26/2010US20100216849 Biphenylcarboxamides
08/26/2010US20100216837 Glycine transport inhibitors
08/26/2010US20100216813 Pyrrolidineanilines
08/26/2010US20100216806 Ortho aminoamides for the treatment of cancer
08/26/2010US20100216803 Ornithine derivative
08/26/2010US20100216792 Pesticidal arylpyrrolidines
08/26/2010US20100216748 Pyrrole Derivatives and Their Methods of Use
08/26/2010US20100216689 Cytotoxic t cell activator comprising ep4 agonist
08/26/2010US20100215594 Tyrosinase Inhibitors
08/26/2010US20100215574 Process for producing an injectable medicament preparation
08/26/2010CA2777743A1 Dihydrolipoic acid derivatives comprising nitric oxide and therapeutic uses thereof
08/26/2010CA2751777A1 Novel ortho-aminoamides for the treatment of cancer
08/26/2010CA2748701A1 Pyrrolidine derivatives as nk3 receptor antagonists
08/25/2010EP2220058A1 Heteroaryl salts and methods for producing and using the same
08/25/2010EP2220030A2 4- (p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
08/25/2010EP2220026A2 Inhibitors of 17beta-hydroxysteroid dehydrogenase
08/25/2010EP1638940B1 Pyrrolidinium derivatives as ligands for the muscarinic m3 receptor
08/25/2010EP0883403B1 Method for treating sexual dysfunctions
08/25/2010CN1775825B Polyaspartimides
08/25/2010CN101815702A Novel crystalline form
08/25/2010CN101812017A CHF4226 in crystalline form and the process for its preparation
08/25/2010CN101812008A IDO inhibitor containing pyrrole-2-aryl structure and preparation method thereof
08/25/2010CN101812007A Aminopyrrole compound and preparation method thereof
08/25/2010CN101812006A Preparation method of 2 (R), 5(R)-di (hydroxymethyl)-3(R),4(R)- 2-hydroxy-pyrrolidine
08/25/2010CN101323584B Oxime ether aryl pyrrole compounds having insecticidal, acaricidal and antifungal bioactivity
08/25/2010CN101239938B Method for preparing (S)-4-hydroxypyrrolidone and derivatives thereof
08/24/2010USRE41549 hair dyes for oxidatively dyeing human hair; comprising a developer and coupler
08/24/2010US7781590 2-(methylamino)-2-oxoethyl 2-[1-(biphenyl-4-ylmethyl)piperidin-4-yl]ethylcarbamate; interacting with cannabinoid and vanilloid receptors; preparation by aminolysis of a 3-(2-piperidin-4-ylethyl)-1,3-oxazolidine-2,4-dione
08/24/2010US7781482 pyrolidone derivatives useful in the treatment of vision defects such as such as post-operative gaucoma, ocular hypertensive episodes, glaucoma, presurgical adjuncts or increased intraocular pressure
08/24/2010US7781475 Oxindoles as kinase inhibitors
08/24/2010US7781474 Inhibitors of hepatitis C virus replication
08/24/2010US7781463 Enzyme inhibitors
08/24/2010US7781461 Neuropeptide Y receptor antagonists comprising 4-(tert-butylsulfonylamino)-N-[5-(trifluoromethyl)pyridin-2-yl]cyclohexane-1-carboxamide and a pharmaceutically acceptable carrier, used for the treatment of obesity and as anorexigenic agents
08/24/2010US7781455 (4R)-3-(2-{[8-(2-Pyrimidinyl)-8-azabicyclo[3.2.1]oct-3-yl]exo-amino}acetyl)thiazolidine-4-carbonitrile; dipeptidylpeptidase-IV enzyme inhibitors; diabetes
08/24/2010CA2621323C Histamine-3 receptor antagonists
08/24/2010CA2488325C Improved process for the preparation of (s)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide and (r)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide
08/24/2010CA2459752C 3-aminocarbonyl-substituted benzoylcyclohexanediones which can be used as herbicides
08/24/2010CA2423103C N-acylsulfonamide apoptosis promoters
08/19/2010WO2010094029A2 Asymmetric cyclopropanation with succinimidyl diazoacetate
08/19/2010WO2010092154A1 Novel substituted indanes, method for the production thereof, and use thereof as drugs
08/19/2010WO2010092153A1 New substituted tetrahydronapthalenes, method for the production thereof, and use thereof as drugs
1 ... 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 ... 404